Intervention

Insulin Degludec/Insulin Aspart

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions1

Lead sponsors shown1

Clinical trials

3 shown

Investigating the Effect of Ryzodeg® in Adult Patients With Type 2 Diabetes in LebanonNCT04892069 · 2021-05-27

A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical PracticeNCT04042441 · 2019-07-29

RESILIENT: A Research Study, Looking at How Ryzodeg® Works in People With Type 2 Diabetes in Local Clinical Practice in JapanNCT03745157 · 2018-11-21

Common conditions

Diabetes Mellitus, Type 23

Leading sponsors

Novo Nordisk A/S3

Trial status mix

COMPLETED3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.